自动化免疫分析法筛查结缔组织病相关抗体的评估
IIF与EliA总符合率为83.1%,EliA阳性对ANA相关系统性风湿病(AASRD)的阳性预测值高于IIF,但EliA可能漏检部分IIF能检出的抗体,两者联合可增加价值。
要点
- EliA阳性患者AASRD比例为30.2%,高于IIF阳性的12.8%。
- 双阳性患者AASRD比例达46.6%,抗体水平越高与AASRD关联越强。
- EliA与IIF联合检测可互补,避免漏检。
核心结论
- EliA对AASRD的阳性预测值高于IIF,但依疾病不同EliA可能漏检IIF可检出的抗体。
- 免疫分析法与IIF联合检测可增加价值。
研究设计与样本
- 回顾2475例病历,包括任一检测阳性/可疑者及500例阴性者。
主要发现
- IIF与EliA符合率为83.1%。
- AASRD在IIF阳性者中占12.8%,EliA阳性者中占30.2%。
- 双阴性、双阳性、EliA单阳性、IIF单阳性者AASRD比例分别为0.4%、46.6%、5.8%、3.0%。
- 抗体水平越高与AASRD关联越强。
- 系统性红斑狼疮(n=83)IIF与EliA阳性率分别为90.4%和69.9%,系统性硬化(n=63)为100%和84.1%,干燥综合征(n=45)为86.7%和93.3%,多发性肌炎/皮肌炎(n=17)为88.2%和52.9%,混合性结缔组织病(n=8)均为阳性。
关键数值与推荐
- EliA特异性预计为94%-96%,IIF为86%。
- 所有AASRD合并分析时,IIF与EliA的ROC曲线下面积相似。
临床怎么用
- EliA可作为IIF的替代筛查方法,但需注意依疾病可能漏检。
- 联合使用EliA与IIF可提高AASRD检出能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antinuclear antibodies (ANAs) are useful for the diagnosis of ANA-associated systemic rheumatic disease (AASRD). The objective of this study was the evaluation of an immunoassay that detects antibodies to a mixture of 17 antigens as an alternative to indirect immunofluorescence (IIF). METHODS: Nine thousand eight hundred and fifty-six consecutive patients tested for ANAs were tested by IIF and EliA connective tissue disease screen (Thermo-Fisher). Medical records were reviewed for 2475 patients, including all patients that tested positive/equivocal by either test and a selection of 500 patients that tested negative. RESULTS: Concordance between IIF and EliA was 83.1%. AASRD was found in 12.8% of IIF-positive patients, 30.2% of EliA-positive patients and 0.4%, 46.6%, 5.8% and 3.0% of patients that tested, respectively, double negative, double positive, single positive for EliA and single positive for IIF. The association with AASRD increased with increasing antibody level. IIF and EliA were positive in, respectively, 90.4% and 69.9% of systemic lupus erythematosus (n=83), 100% and 84.1% of systemic sclerosis (n=63), 86.7% and 93.3% of Sjögren's syndrome (n=45), 88.2% and 52.9% of polymyositis/dermatomyositis (n=17), and in all cases of mixed connective tissue disease (n=8). The specificity was projected to be 94%-96% for EliA and 86% for IIF. When all AASRDs were taken together, the areas under the curve of receiver operator curves were similar between IIF and EliA. CONCLUSIONS: The positive predictive value for AASRD was higher for EliA than for IIF, but, depending on the disease, EliA might fail to detect antibodies that are detected by IIF. Combining immunoassay with IIF adds value.
引用
- Willems P, De Langhe E, Claessens J, et al. Screening for connective tissue disease-associated antibodies by automated immunoassay. Clin Chem Lab Med. 2018. PMID: 29306915. doi:10.1515/cclm-2017-0905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。